ERBB2 and breast carcinoma: Nevertheless, it is worth exploring the potential efficacy of HV-107 in treating other cancers, such as HER2 + breast cancer, where the overexpression or hyperactivation of Rac has been associated with acquired resistance to chemotherapy (Sun et al. 2021).